| Q93163570 | Addition of Metabolic Syndrome to Albuminuria Provides a New Risk Stratification Model for Diabetic Kidney Disease Progression in Elderly Patients |
| Q37248776 | Alcohol consumption and metabolic syndrome among Shanghai adults: a randomized multistage stratified cluster sampling investigation |
| Q44198279 | Analysis of the criteria used for the definition of metabolic syndrome in patients with type 2 diabetes mellitus |
| Q40107256 | Association Between Chronic Conditions and Physical Function Among Veteran and Non-Veteran Women With Diabetes |
| Q35865738 | Association between sedentary and physical activity patterns and risk factors of metabolic syndrome in Saudi men: A cross-sectional study |
| Q36359500 | Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension |
| Q39715539 | Demographic and clinical correlates of metabolic syndrome in Native African type-2 diabetic patients. |
| Q38740026 | Depression is Associated with Increased Risk for Metabolic Syndrome in Latinos with Type 2 Diabetes |
| Q42936496 | Differential effects of pioglitazone on metabolic parameters in newly diagnosed, drug-naïve Japanese patients with type 2 diabetes with or without metabolic syndrome |
| Q39949079 | Dyslipidemia in Shanghai, China |
| Q53241727 | Eating behavior affects quality of life in type 2 diabetes mellitus. |
| Q34503417 | Effects of genetic variants on lipid parameters and dyslipidemia in a Chinese population |
| Q46841528 | Fatty liver and the metabolic syndrome among Shanghai adults |
| Q33616618 | High Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ Functions |
| Q92837857 | Hypoadiponectemia is associated with metabolic syndrome in patients with type 2 diabetes |
| Q35799650 | Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study |
| Q48308334 | Impaired secretion of active GLP-1 in patients with hypertriglyceridaemia: A novel lipotoxicity paradigm? |
| Q35918777 | Inflammation, insulin resistance, and obesity. |
| Q36297331 | Insulin resistance: a metabolic pathway to chronic liver disease |
| Q90166727 | Magnitude of metabolic syndrome and its associated factors among patients with type 2 diabetes mellitus in Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia: a cross sectional study |
| Q30570152 | Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus |
| Q36125522 | Metabolic syndrome among Sri Lankan adults: prevalence, patterns and correlates |
| Q36449377 | Metabolic syndrome is not associated with reduction in aortic distensibility in subjects with type 2 diabetes mellitus |
| Q36301900 | Metabolic syndrome related to cardiovascular events in a 10-year prospective study |
| Q96129205 | Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome |
| Q35131027 | Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state |
| Q37060883 | Optimal cut-off levels of obesity indices by different definitions of metabolic syndrome in a southeast rural Chinese population |
| Q93081634 | Polymorphisms in PCSK9, LDLR, BCMO1, SLC12A3, and KCNJ1 are Associated with Serum Lipid Profile in Chinese Han Population |
| Q64905006 | Predictors of vascular complications among type 2 diabetes mellitus patients at University of Gondar Referral Hospital: a retrospective follow-up study. |
| Q36227925 | Prevalence and Risk Factors Associated with Dyslipidemia in Chongqing, China |
| Q41081436 | Prevalence and determinants of the metabolic syndrome among subjects with advanced nondiabetes-related chronic kidney disease in Gran Canaria, Spain |
| Q34360571 | Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14) |
| Q35997248 | Prevalence of and Risk Factors for Type 2 Diabetes Mellitus in Hyperlipidemia in China |
| Q35003229 | Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review |
| Q46885839 | Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals |
| Q33930766 | Prevalence, components and associated demographic and lifestyle factors of the metabolic syndrome in type 2 diabetes mellitus. |
| Q34014004 | Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity |
| Q41955690 | Steroid-induced diabetes: is it just unmasking of type 2 diabetes? |
| Q40106543 | The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice |
| Q45309415 | The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects |
| Q33569142 | The metabolic syndrome |
| Q34040213 | Waist circumference, not the metabolic syndrome, predicts glucose deterioration in type 2 diabetes |